Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis (Q80892751)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Kazuhiro Komura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

C Nishijima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

I Hayakawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

M Hasegawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

K Takehara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

S Sato

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

357-363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15498049%20AND%20SRC:MED&resulttype=core&format=json

The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family

4 January 2020

cites work

1 reference

12 December 2020

Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis

1 reference

12 December 2020

Pathogenesis of scleroderma. Collagen

1 reference

12 December 2020

Antinuclear antibody in systemic sclerosis (scleroderma).

1 reference

12 December 2020

Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts

1 reference

12 December 2020

Human connective tissue growth factor is expressed in advanced atherosclerotic lesions

1 reference

12 December 2020

Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis

1 reference

12 December 2020

Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts

1 reference

12 December 2020

Expression of connective tissue growth factor in experimental rat and human liver fibrosis

1 reference

12 December 2020

Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis

1 reference

12 December 2020

Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.

1 reference

12 December 2020

CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis

1 reference

12 December 2020

Quantitative genetic variation in CD19 expression correlates with autoimmunity

1 reference

12 December 2020

CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling

1 reference

12 December 2020

Renal vascular damage in Japanese patients with systemic sclerosis

1 reference

12 December 2020

A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR.

1 reference

12 December 2020

Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls

1 reference

12 December 2020

Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis.

1 reference

12 December 2020

Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165

1 reference

12 December 2020

Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis

1 reference

12 December 2020

Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast

1 reference

12 December 2020

Polymyositis and dermatomyositis (second of two parts)

1 reference

12 December 2020

Polymyositis and dermatomyositis (first of two parts)

1 reference

12 December 2020

Pathogenesis of systemic sclerosis: A vascular hypothesis

1 reference

12 December 2020

Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation

1 reference

12 December 2020

Characterization of dermal collagen in systemic sclerosis

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Increased expression of type VI collagen genes in systemic sclerosis

1 reference

12 December 2020

How matrix metalloproteinases regulate cell behavior

1 reference

12 December 2020

Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-beta

1 reference

12 December 2020

Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10

1 reference

12 December 2020

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

12 December 2020

Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair

1 reference

12 December 2020

Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

1 reference

12 December 2020

Decreased collagenase expression in cultured systemic sclerosis fibroblasts

1 reference

12 December 2020

Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1.

1 reference

12 December 2020

CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse

1 reference

12 December 2020

Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis

1 reference

12 December 2020